-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Voyager Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
- Voyager Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.91M, a 49.8% increase year-over-year.
- Voyager Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $16.4M, a 76.4% increase year-over-year.
- Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $11.7M, a 164% increase from 2022.
- Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $4.45M, a 83.6% increase from 2021.
- Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $2.42M, a 74.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)